Unknown PHASE1 INTERVENTIONAL 2-arm NCT00726960

Ability of Aprepitant to Block Opioid Reward in Non-Dependent Opiate Abusers

Modulation of Opiate Reward by NK1 Antagonism: A Laboratory-Based Proof of Concept Study

Sponsor: County of Stockholm

Conditions Heroin Dependence Opioid-Related Disorders Substance-Related Disorders

Interventions Pseudo-placebo - buprenorphine aprepitant

Updated 4 times since 2017 Last updated: Jul 30, 2008 Started: Jan 31, 2008 Primary completion: Dec 31, 2009 Completion: Jun 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Heroin Dependence and Opioid-Related Disorders and is currently ongoing. County of Stockholm leads this study, which shows 4 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE1

First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

County of Stockholm
Karolinska University Hospital
Ministry of Health and Social Affairs, Sweden

Data source: Karolinska University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stockholm, Sweden